{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-006754","form_type":"8-K","ticker":null,"cik":"0001629205","company_name":"Innovation1 Biotech Inc.","filed_at":"2023-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.613416+00:00","generated_at":"2026-06-10T22:12:05.387292+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Innovation1 Biotech closes $78,695 secured convertible note + warrant financing","bullets":["Gross proceeds of $66,891 from $78,695 principal amount 8% secured convertible notes due Sept 30, 2024.","Notes convertible at $0.08/share; 983,693 warrants issued with $0.08 exercise price.","Transaction completed with two purchasers; securities unregistered under Rule 506(b).","Notes include 4.99% beneficial ownership limitation and secured by company assets."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-006754","json":"https://secwatch.observer/filing/0001477932-23-006754.json","markdown":"https://secwatch.observer/filing/0001477932-23-006754.md","text":"https://secwatch.observer/filing/0001477932-23-006754.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1629205/000147793223006754/0001477932-23-006754-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1629205/000147793223006754/ivbt_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:12:05.387292+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9895d19516ddfb26216c7b7a373cb9749b2752cc","claim":"Innovation1 Biotech Inc. incurred convertible notes of $78,695 with two lenders (the \"Purchasers\") at 8% per annum maturing September 30, 2024.","evidence_excerpt":"On September 1, 2023, Innovation1 Biotech Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Agreement”) with two lenders (the “Purchasers”), pursuant to which the Company issued and sold the Purchasers Original Issue Discount Secured Convertible Promissory Notes in the principal amount of $78,695 (collectively, the “Notes”) for gross proceeds of $66,891.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1629205/000147793223006754/0001477932-23-006754-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$78,695"},{"label":"Counterparty","value":"two lenders (the \"Purchasers\")"},{"label":"Rate","value":"8% per annum"},{"label":"Maturity","value":"September 30, 2024"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"3cb0a210644c024b7ee1a62d9913b29024d7e634","claim":"Innovation1 Biotech Inc. entered into Securities Purchase Agreement with two lenders (the “Purchasers”) valued at principal amount of $78,695 (effective 2023-09-01).","evidence_excerpt":"On September 1, 2023, Innovation1 Biotech Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Agreement”) with two lenders (the “Purchasers”), pursuant to which the Company issued and sold the Purchasers Original Issue Discount Secured Convertible Promissory Notes in the principal amount of $78,695 (collectively, the “Notes”) for gross proceeds of $66,891.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1629205/000147793223006754/0001477932-23-006754-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"two lenders (the “Purchasers”)"},{"label":"Value","value":"principal amount of $78,695"},{"label":"Effective","value":"2023-09-01"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}